Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Cari Berget to Insulin Infusion Systems

This is a "connection" page, showing publications Cari Berget has written about Insulin Infusion Systems.

 
Connection Strength
 
 
 
3.217
 
  1. Berget C, Lange S, Messer L, Forlenza GP. A clinical review of the t:slim X2 insulin pump. Expert Opin Drug Deliv. 2020 12; 17(12):1675-1687.
    View in: PubMed
    Score: 0.612
  2. Berget C, Messer LH, Vigers T, Frohnert BI, Pyle L, Wadwa RP, Driscoll KA, Forlenza GP. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system. Pediatr Diabetes. 2020 03; 21(2):310-318.
    View in: PubMed
    Score: 0.584
  3. Berget C, Thomas SE, Messer LH, Thivener K, Slover RH, Wadwa RP, Alonso GT. A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic. J Diabetes Sci Technol. 2020 03; 14(2):290-296.
    View in: PubMed
    Score: 0.552
  4. Messer LH, Berget C. Hybrid Closed-Loop Systems to Date: Hype Versus Reality. Diabetes Technol Ther. 2023 01; 25(1):91-94.
    View in: PubMed
    Score: 0.177
  5. Berget C, Akturk HK, Messer LH, Vigers T, Pyle L, Snell-Bergeon J, Driscoll KA, Forlenza GP. Real-world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed-loop use. Diabetes Obes Metab. 2021 09; 23(9):2048-2057.
    View in: PubMed
    Score: 0.161
  6. Messer LH, Berget C, Ernst A, Towers L, Slover RH, Forlenza GP. Initiating hybrid closed loop: A program evaluation of an educator-led Control-IQ follow-up at a large pediatric clinic. Pediatr Diabetes. 2021 06; 22(4):586-593.
    View in: PubMed
    Score: 0.159
  7. Berget C, Wykoff L. Use of Technology in Managing Diabetes in Youth, Part 1: Continuous Glucose Monitoring: Information and Tips for the School Nurse. NASN Sch Nurse. 2020 Mar; 35(2):63-69.
    View in: PubMed
    Score: 0.147
  8. Messer LH, Berget C, Vigers T, Pyle L, Geno C, Wadwa RP, Driscoll KA, Forlenza GP. Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months. Pediatr Diabetes. 2020 03; 21(2):319-327.
    View in: PubMed
    Score: 0.146
  9. Sherr JL, Buckingham BA, Forlenza GP, Galderisi A, Ekhlaspour L, Wadwa RP, Carria L, Hsu L, Berget C, Peyser TA, Lee JB, O'Connor J, Dumais B, Huyett LM, Layne JE, Ly TT. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technol Ther. 2020 03; 22(3):174-184.
    View in: PubMed
    Score: 0.144
  10. Messer LH, Berget C, Forlenza GP. A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm. Diabetes Technol Ther. 2019 08; 21(8):462-469.
    View in: PubMed
    Score: 0.140
  11. Messer LH, Berget C, Beatson C, Polsky S, Forlenza GP. Preserving Skin Integrity with Chronic Device Use in Diabetes. Diabetes Technol Ther. 2018 06; 20(S2):S254-S264.
    View in: PubMed
    Score: 0.131
  12. Forlenza GP, Vigers T, Berget C, Messer LH, Lal RA, Basina M, Maahs DM, Hood K, Buckingham B, Wilson DM, Wadwa RP, Driscoll KA, Pyle L. Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study. Diabetes Technol Ther. 2022 03; 24(3):157-166.
    View in: PubMed
    Score: 0.042
  13. Messer LH, Berget C, Pyle L, Vigers T, Cobry E, Driscoll KA, Forlenza GP. Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes. Diabetes Technol Ther. 2021 12; 23(12):837-843.
    View in: PubMed
    Score: 0.040
  14. Forlenza GP, Buckingham BA, Brown SA, Bode BW, Levy CJ, Criego AB, Wadwa RP, Cobry EC, Slover RJ, Messer LH, Berget C, McCoy S, Ekhlaspour L, Kingman RS, Voelmle MK, Boyd J, O'Malley G, Grieme A, Kivilaid K, Kleve K, Dumais B, Vienneau T, Huyett LM, Lee JB, O'Connor J, Benjamin E, Ly TT. First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2021 06; 23(6):410-424.
    View in: PubMed
    Score: 0.039
  15. Ekhlaspour L, Schoelwer MJ, Forlenza GP, DeBoer MD, Norlander L, Hsu L, Kingman R, Boranian E, Berget C, Emory E, Buckingham BA, Breton MD, Wadwa RP. Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers. Diabetes Technol Ther. 2021 05; 23(5):384-391.
    View in: PubMed
    Score: 0.039
  16. Cobry EC, Berget C, Messer LH, Forlenza GP. Review of the Omnipod? 5 Automated Glucose Control System Powered by Horizon? for the treatment of Type 1 diabetes. Ther Deliv. 2020 08; 11(8):507-519.
    View in: PubMed
    Score: 0.038
  17. O'Donnell HK, Berget C, Wooldridge JS, Driscoll KA. Graduated exposure to treat fear of hypoglycemia in a young adult with type 1 diabetes: A case study. Pediatr Diabetes. 2019 02; 20(1):113-118.
    View in: PubMed
    Score: 0.034
  18. Forlenza GP, Messer LH, Berget C, Wadwa RP, Driscoll KA. Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field. Curr Diab Rep. 2018 09 26; 18(11):114.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)